白细胞介素33在易发胃炎小鼠慢性模型中触发早期嗜酸性粒细胞依赖性事件导致化生
研究在易发胃炎的SAMP1/YitFc小鼠中探讨IL33在慢性炎症与胃化生之间的作用。结果显示SAMP小鼠出现进行性胃炎和肠化生性SPEM,伴嗜酸性粒细胞扩增和IL33阳性M2巨噬细胞局部募集;IL33阻断减少M2巨噬细胞和SPEM,而嗜酸性粒细胞清除减少局部IL33阳性M2巨噬细胞和SPEM。作者认为IL33通过嗜酸性粒细胞依赖的下游M2巨噬细胞浸润促进化生。
要点
- SAMP小鼠出现进行性胃炎并最终发生肠化生性SPEM,AKR小鼠无此表现。
- SAMP小鼠骨髓嗜酸性粒细胞扩增,局部募集嗜酸性粒细胞和IL33阳性M2巨噬细胞。
- IL33阻断减少M2巨噬细胞和SPEM;嗜酸性粒细胞清除减少局部IL33阳性M2巨噬细胞和SPEM。
核心结论
- IL33通过嗜酸性粒细胞依赖的下游IL33阳性M2巨噬细胞浸润促进化生,导致SAMP小鼠肠化生性SPEM。
- 作者认为IL33是慢性胃炎与肠化生之间的关键链接,可能作为胃肠道癌前病变的潜在治疗靶点。
研究设计与样本
- 研究使用易发胃炎的SAMP1/YitFc(SAMP)小鼠和亲本对照AKR小鼠,评估基线胃炎及向化生的进展。
- 在胃体组织中表征IL33及其受体ST2/IL1R4的表达与定位,并进行靶向IL33/ST2轴的激活和中和研究。
- 通过抗IL5/抗CCR3治疗进行嗜酸性粒细胞清除研究,评估导致化生的免疫通路。
主要发现
- SAMP小鼠胃内检测到进行性胃炎并最终出现肠化生性SPEM,AKR小鼠无此表现,但外源性重组IL33可中度诱导。
- SAMP小鼠出现明显的外周(骨髓)嗜酸性粒细胞扩增,以及嗜酸性粒细胞和表达IL33的M2巨噬细胞向胃体组织的局部募集。
- IL33阻断不影响骨髓来源嗜酸性粒细胞扩增和局部浸润,但显著减少M2巨噬细胞和SPEM特征。
- 嗜酸性粒细胞清除导致SAMP小鼠局部IL33阳性M2巨噬细胞和SPEM显著减少。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Interleukin (IL)33/IL1F11 is an important mediator for the development of type 2 T-helper cell (Th2)-driven inflammatory disorders and has also been implicated in the pathogenesis of gastrointestinal (GI)-related cancers, including gastric carcinoma. We therefore sought to mechanistically determine IL33's potential role as a critical factor linking chronic inflammation and gastric carcinogenesis using gastritis-prone SAMP1/YitFc (SAMP) mice. METHODS: SAMP and (parental control) AKR mice were assessed for baseline gastritis and progression to metaplasia. Expression/localization of IL33 and its receptor, ST2/IL1R4, were characterized in corpus tissues, and activation and neutralization studies were both performed targeting the IL33/ST2 axis. Dissection of immune pathways leading to metaplasia was evaluated, including eosinophil depletion studies using anti-IL5/anti-CCR3 treatment. RESULTS: Progressive gastritis and, ultimately, intestinalized spasmolytic polypeptide-expressing metaplasia (SPEM) was detected in SAMP stomachs, which was absent in AKR but could be moderately induced with exogenous, recombinant IL33. Robust peripheral (bone marrow) expansion of eosinophils and local recruitment of both eosinophils and IL33-expressing M2 macrophages into corpus tissues were evident in SAMP. Interestingly, IL33 blockade did not affect bone marrow-derived expansion and local infiltration of eosinophils, but markedly decreased M2 macrophages and SPEM features, while eosinophil depletion caused a significant reduction in both local IL33-producing M2 macrophages and SPEM in SAMP. CONCLUSIONS: IL33 promotes metaplasia and the sequelae of eosinophil-dependent downstream infiltration of IL33-producing M2 macrophages leading to intestinalized SPEM in SAMP, suggesting that IL33 represents a critical link between chronic gastritis and intestinalizing metaplasia that may serve as a potential therapeutic target for preneoplastic conditions of the GI tract.
引用
- De Salvo C, Pastorelli L, Petersen CP, et al. Interleukin 33 Triggers Early Eosinophil-Dependent Events Leading to Metaplasia in a Chronic Model of Gastritis-Prone Mice. Gastroenterology. 2020. PMID: 33010253. doi:10.1053/j.gastro.2020.09.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。